Glycans as Biomarkers and Functional Effectors in Diabetes and Cardiovascular Diseases
Author: Prof Gordan Lauc, PhD
Published: March 24, 2020
Author: Prof Gordan Lauc, PhD
Category: Glycoscience
Glycan science and biological age
Go deeper with GlycanAge for research and cohort studies, peer-reviewed GlycanAge research case studies, and methodology behind glycan-based biological age testing.
The Future of Healthcare is Preventative, Personalised, and Powered by Glycans
Whether you’re improving your own health, supporting patients, or driving research, GlycanAge helps you turn science into action.
Other articles you may like:
Glycoscience The GlycanAge Team Published:
September 8, 2026
Reading time:
10 minutes
Read the full articleExecutive Health Programs: Why Inflammaging Is the Missing Biomarker in Corporate Wellness
Explore the significance of inflammaging in executive health programs and its role as a crucial biomarker for advancing corporate wellness initiatives.
Published:September 8, 2026
Reading time:10 minutes
Glycoscience The GlycanAge Team Published:
September 8, 2026 Reading time:
10 minutes
Read the full articleWhat Tests Do Anti-Aging Doctors Use to Prove Patient Protocols Work? A Practitioner's Guide
Discover the essential tests anti-aging doctors utilize to validate patient protocols. Explore this comprehensive guide for insights into effective aging strategies.
Published:September 8, 2026
Reading time:10 minutes